Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGAP8 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | RBM8A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | ITGA6 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
mRNA | PRNP | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
mRNA | TSPAN14 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | EAF1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | POLR2B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | KIF18B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | ZNF775 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
mRNA | TSPAN6 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |